Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 82804-086

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 82804-086). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

82804-086-07 (Image 01)

Label for Emtricitabine and tenofovir disoproxil fumarate 200 mg / 300 mg film-coated tablets by Proficient Rx LP. The label includes the NDC 82804-086 and instructions to dispense a separate medication guide. Tablets are described as white to off-white, capsule-shaped, film-coated with debossed markings. Manufactured by HETERO Labs Limited, India.*

FDA Label Image

Structure-1 (Structure 1)

Chemical structure of emtricitabine, an active ingredient in the Emtricitabine and tenofovir disoproxil fumarate tablet product by Proficient Rx LP.*

FDA Label Image

Structure-2 (Structure 2)

Chemical structure of emtricitabine and tenofovir disoproxil fumarate, the active ingredients in the tablet formulation. The diagram shows the molecular structure including atoms and bonds, with an additional formic acid component depicted alongside.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.